Clinical trial
A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant…
NCT00321152 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00321152 |
|---|---|
| Title | A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) |
| Official title | A Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF Among SSRI-Resistant Outpatients With Major Depressive Disorder (MDD) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Pamlab, L.L.C. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Other |
| Interventions | 6(S)-5-MTHF (a Medical Food) |
| Enrollment | 150 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Jun 1, 2010 |
| First posted | May 3, 2006 |
| Last update posted | Jun 8, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: